News & Events

Simtra BioPharma Solutions announces the purchase from Cook Group of a 65-acre property with more than 300,000 square feet of available space for expansion under-roof near its existing manufacturing facility in Bloomington, Indiana.

Simtra announced today that it completed the construction of its new production manufacturing building at its campus in Halle, Germany.

Simtra's Head of Development, Lidia Serina, spoke with Contract Pharma about our expansion, the move to unify workstreams across sites, and how we are working to shorten developmental timelines.

Simtra BioPharma Solutions announced that it has formed a five-year strategic alliance with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada.

Simtra CCO, James Garrett, discusses the recent sustainability report with BioProcess International, sharing Simtra's commitment to environmental, social, and governance initiatives.

Companies choosing to outsource formulation science should seek a CDMO partner that not only brings expertise beyond what’s available internally but is equally invested in the product’s success.

Simtra BioPharma Solutions announces the publication of its inaugural Sustainability Report for the year ended December 31, 2024.

On the latest episode of Drug Digest, Lidia Serina, Ph.D., Head of Development Services at Simtra BioPharma Solutions, discusses three advanced modalities that she believes are shaping the pharmaceutical industry, including antibody-drug conjugates (ADCs) for oncology treatments. 

 

Simtra is driving the future of sterile injectable manufacturing with cutting-edge investments in ADCs, expanded fill-finish capacity, and enhanced development services. As the demand for complex therapies grows, our commitment to quality, efficiency, and patient-centered innovation has never been stronger.